Jazz Pharmaceuticals Aktie

Jazz Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A1JS1K / ISIN: IE00B4Q5ZN47

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
24.02.2016 10:58:28

Earnings Reported After The Bell Feb. 23

(RTTNews) - Here is a quick summary of the earnings reported after the bell on Feb. 23.

AtriCure, Inc. (ATRC)

Q4 net loss was $10.91 million or $0.36 per share vs. net loss of $5.34 million or $0.20 per share a year ago.

Revenue for the fourth quarter was $35.86 million vs. $29.42 million a year ago.

FY Outlook

Revenue growth of approximately 25% .

***

Wright Medical Group N.V. (WMGI)

Q4 net loss from continuing operations was $92.2 million, or $0.90 per share vs. loss of $106.97 million or $2.05 per share a year ago.

Net sales totaled $176.97 million during the fourth quarter vs. $83.29 million a year ago.

FY Outlook

Net sales to be in the range of $695 million to $705 million.

Adjusted loss per share to be in the range of $0.65 to $0.71.

***

Edison International (EIX)

Q4 net loss was $79 million, or $0.24 per share, compared to net income of $420 million, or $1.29 per share a year ago.

Core earnings were $287 million, or $0.88 per share, compared to $355 million, or $1.08 per share a year ago.

Q4 revenue was $2.34 million vs. $3.11 million a year ago.

Analysts expected the company to report net income of $0.60 per share on revenues of $3.34 billion for the period.

***

DexCom, Inc. (DXCM)

Q4 GAAP net income was $1.5 million, or $0.02 per share compared to $1.3 million, or $0.02 per share a year ago.

Total revenue grew to $130.8 million for the fourth quarter from $84.3 million a year ago.

Analysts expected the company to report net income of $0.01 per share on revenues of $123.74 million for the period.

***

Tetraphase Pharmaceuticals, Inc. (TTPH)

Q4 net loss was $18.1 million, or $0.50 per share, compared to a net loss of $20.6 million, or $0.69 per share a year ago.

Revenues were $2.5 million compared to $3.1 million for the same period last year.

***

Foundation Medicine (FMI)

Q4 net loss was $19.0 million or $0.55 per share vs. net loss of $13.3 million or $0.47 per share a year ago.

Revenue was $26.1 million compared to $18.7 million a year ago.

FY Outlook

Revenue to be in the range of $110 million to $120 million.

***

Care.com, Inc. (CRCM)

Q4 income from continuing operations was $3.68 million or $0.11 per share compared to loss of $1.53 million or $0.05 per share a year ago.

Non-GAAP EPS was $0.15.

Fourth quarter revenue increased 25% to$37.55 million from $29.99 million a year ago.

Analysts expected the company to report net income of $0.09 per share on revenues of $38.77 million for the period.

Q1 Outlook

Revenue to be in the range of $37.5 million - $38.5 million.

Non-GAAP loss per share to be in the range of $ (0.07) - $(0.04)

Analysts expect the company to report net loss of $0.14 per share on revenues of $39.63 million for the period.

FY Outlook

Revenue to be in the range of $155.0 million- $161.0 million.

Non-GAAP EPS to be in the range of $0.05 - $0.15.

Analysts expect the company to report net loss of $0.09 per share on revenues of $162.82 million for the period.

***

Caesars Entertainment Corporation (CZR)

Q4 net loss attributable to Caesars was $76 million or $0.54 per share vs. loss of $1.023 billion or $6.98 per share a year ago.

Net revenues were $1.119 billion vs. $2.131 billion a year ago.

***

Matson, Inc. (MATX)

Q4 net income was $26.6 million, or $0.60 per share vs. $27.8 million, or $0.63 per share a year ago.

Consolidated revenue for the fourth quarter was $494.8 million compared with $443.5 million a year ago.

Analysts expected the company to report net income of $0.62 per share on revenues of $517.27 million for the period.

***

Infinity Pharmaceuticals, Inc. (INFI)

Q4 net loss was $39.19 million or $0.80 per share vs. net loss of $40.34 million or $0.83 per share a year ago.

Q4 Collaboration revenue was $9.08 million vs. $4.36 million a year ago.

FY Outlook

Revenue to range from $225 million to $245 million.

Net income to range from $15 million to $35 million.

***

WebMD Health Corp. (WBMD)

Q4 net income was $27.5 million or $0.60 per share, compared to $16.3 million, or $0.38 per share in the prior year period.

Q4 revenue was $192.1 million, compared to $162.7 million in the prior year period

Analysts expected the company to report net income of $0.57 per share on revenues of $189.93 million for the period.

Q1 Outlook

Revenue to be in the range of $154.5 million to $157.5 million.

Analysts expect the company to report revenues of $154.60 million for the period.

Net income to be in the range of $13.2 million to $14.7 million.

FY Outlook

Revenue to be in the range of $685 million to $705 million.

EPS to be in the range of $1.75 to $1.90.

Analysts expect the company to report net income of $1.66 per share on revenues of $689.91 million for the period.

***

Caesars Acquisition Company (CACQ)

Q4 net income was $8.5 million or $0.06 per share vs. $1.2 million or $0.01 per share a year ago.

Revenues were nil vs. nil a year ago.

***

DreamWorks Animation SKG, Inc. (DWA)

Q4 net income was $42.07 million, or $0.48 per share vs. net loss of $263.22 million or $3.08 per share a year ago.

Adjusted net income attributable to DWA for the quarter was $48.1 million, or $0.55 per share.

Revenues were $319.3 million versus $234.24 million in the prior-year period

***

Rubicon Project (RUBI)

Q4 net income was $20.4 million, or $0.43 per share vs. $1.4 million or $0.04 per share a year ago.

Non-GAAP earnings per share was $0.72 vs. $0.25 a year ago.

GAAP revenue was $94.0 million vs. $41.8 million a year ago.

Non-GAAP net revenue was $83.7 million vs. $41.8 million a year ago.

Analysts expected the company to report net income of $0.33 per share on revenues of $78 million for the period.

Q1 Outlook

GAAP revenue to be in the range of $64 million - $68 million.

Non-GAAP net revenue to be in the range of $58 million - $60 million.

Non-GAAP earnings per share to be in the range of $0.00 to $0.02

Analysts expect the company to report net income of $0.04 per share on revenues of $61.09 million for the period.

FY Outlook

GAAP revenue to be in the range of $315 million - $355 million

Non-GAAP net revenue to be in the range of $275 million - $295 million

Non-GAAP earnings per share to be in the range of $0.65 to $0.78

Analysts expect the company to report net income of $0.72 per share on revenues of $288.87 million for the period.

***

Ixia (XXIA)

Q4 net income was $5.8 million, or $0.07 per share, compared with $0.3 million, or $0.00 per share a year ago.

Non-GAAP net income was $18.7 million, or $0.22 per share, compared with $15.6 million, or $0.19 per share a year ago.

Total revenue was $138.5 million, up 9 percent, compared with $127.2 million a year ago.

Analysts expected the company to report net income of $0.15 per share on revenues of $129.90 million for the period.

***

Intersect ENT Inc. (XENT)

Q4 net loss was $5.7 million or $0.20 per share compared to $3.7 million or $0.16 per share for the same period of 2014.

Revenue for the fourth quarter of 2015 increased 40% to $18.8 million from $13.4 million for the same period of 2014.

***

GenMark Diagnostics, Inc. (GNMK)

Q4 net loss was $8.78 millio9n or $0.21 per share vs. net loss of $8.61 million or $0.21 per share a year ago.

Revenue for the fourth quarter was $13.19 million, an increase of 34% over $9.83 million a year ago.

FY Outlook

Revenue to be in the range of $47 million to $51 million.

***

First Solar, Inc. (FSLR)

Q4 net income was $164.14 million, or $1.60 per share vs. $193.32 million, or $1.90 per share, in last year's fourth quarter.

Revenue for the quarter fell 6.9% to $0.94 billion from $1.01 billion last year.

Analysts expected the company to report net income of $0.78 per share on revenues of $929.01 million for the period.

FY Outlook

EPS to be in the range of $4.00 - $4.50.

Revenue to be in the range of $3.8 billion to $4.0 billion vs. prior guidance of $3.9 billion to $4.1 billion.

Analysts expect the company to report net income of $4.12 per share on revenues of $3.83 billion for the period.

***

ARC Document Solutions, Inc. (ARC)

Q4 net income attributable to ARC was $3.1 million or $0.06 per share vs. loss of $2.3 million or $0.05 per share a year ago.

Adjusted earnings were $3.2 million or $0.07 per share vs. $2.6 million or $0.06 per share a year ago.

Net revenue was $104.5 million vs. $107.6 million a year ago.

Analysts expected the company to report net income of $0.06 per share on revenues of $104.44 million for the period.

FY Outlook

Adjusted earnings per share to be in the range of $0.30 to $0.35.

Analysts expect the company to report net income of $0.41 per share for the period.

***

Masimo (MASI)

Q4 GAAP net income was $24.1 million, or $0.46 per share, compared to $21.2 million, or $0.40 per share a year ago.

Non-GAAP net income was $7.7 million, or $0.15 per share, versus $21.5 million or $0.40 per share in the year-ago period.

Total revenue rose 3.4% to $167.27 million from $161.79 million a year ago.

Analysts expected the company to report net income of $0.39 per share on revenues of $164.25 million for the period.

FY Outlook

Masimo expects fiscal 2016 GAAP earnings per share to be approximately $1.69.

2016 non-GAAP earnings per share to be approximately $1.74.

Masimo expects fiscal 2016 total product revenues to be approximately $670.0 million.

Analysts expect the company to report net income of $1.67 per share on revenues of $666.21 million for the period.

***

RealPage, Inc. (RP)

Q4 GAAP net income was $3.9 million, or $0.05 per share, compared to $0.1 million, or $0.00 per share, in the prior year quarter.

Non-GAAP net income was $12.5 million, or $0.16 per share.

GAAP revenue was $121.7 million vs. $104.46 million a year ago.

Non-GAAP revenue was $121.2 million.

Analysts expected the company to report net income of $0.15 per share on revenues of $121.19 million for the period.

Q1 Outlook

Non-GAAP revenue is expected to be in the range of $125.0 million to $127.0 million.

Non-GAAP net income per share is expected to be $0.16.

Analysts expect the company to report net income of $0.15 per share on revenues of $125.34 million for the period.

FY Outlook

Non-GAAP revenue is expected to be in the range of $565.0 million to $575.0 million.

Non-GAAP net income per share is expected to be in the range of $0.68 to $0.72.

Analysts expect the company to report net income of $0.63 per share on revenues of $523.38 million for the period.

***

BioBlast Pharma Ltd. (ORPN)

Q4 net loss was $4.8 million, or $0.34 per share, compared with net loss of $3.2 million, or $0.22 per share a year ago.

***

Alder BioPharmaceuticals, Inc. (ALDR)

Q4 net loss was $26.2 million, or $0.60 per share, compared to net loss of $6.9 million, or $0.22 per share a year ago.

In Q4, Alder did not record any revenues compared to $6.4 million last year.

***

Enphase Energy, Inc. (ENPH)

Q4 GAAP net loss was $15.8 million, or $0.35 per share vs. net income of $402000 or $0.01 per share a year ago.

Non-GAAP net loss was $11.5 million, or $0.25 per share.

Total revenue was $65.63 million vs. $105.21 million a year ago.

Q1 Outlook

Revenue to be in the range of $63 million to $69 million.

***

Jazz Pharmaceuticals plc (JAZZ)

Q4 GAAP net income attributable to Jazz Pharmaceuticals plc was $82.8 million, or $1.32 per share, compared to $81.6 million, or $1.30 per share a year ago.

Adjusted net income attributable to Jazz Pharmaceuticals plc for the fourth quarter was $163.5 million, or $2.60 per share, compared to $151.1 million, or $2.40 per share a year ago.

Revenue was $340.88 million vs. $328.14 million a year ago.

Analysts expected the company to report net income of $2.60 per share on revenues of $349.83 million for the period.

FY Outlook

Revenues to be in the range of $1,490 million -$1,550 million.

GAAP net income per share to be in the range of $6.76-$7.41.

Adjusted net income per share to be in the range of $10.90-$11.30.

Analysts expect the company to report net income of $11.42 per share on revenues of $1.54 billion for the period.

***

Five9, Inc. (FIVN)

Q4 GAAP net loss was $3.5 million, or $0.07 per share, compared to a net loss of $9.4 million, or $0.19 per share a year ago.

Non-GAAP net loss was $1.6 million, or $0.03 per share, compared to loss of $6.8 million, or $0.14 per share a year ago.

Total revenue for the fourth quarter increased 27% to $36.0 million compared to $28.3 million a year ago.

Q1 Outlook

Revenue to be in the range of $35.5 million to $36.5 million.

GAAP net loss per share to be in the range of $0.10 to $0.12.

Non-GAAP net loss per share to be in the range of $0.06 to $0.08.

FY Outlook

Revenue to be in the range of $148 million to $151 million.

GAAP net loss per share to be in the range of $0.39 to $0.44.

Non-GAAP net loss per share to be in the range of $0.21 to $0.27.

***

Bravo Brio Restaurant Group, Inc. (BBRG)

Q4 GAAP net loss was $2.7 million, or $0.18 per share, compared to net income of $3.8 million, or $0.20 per share a year ago.

Adjusted net income was $3.6 million, or $0.23 per share, compared to $4.2 million, or $0.22 per share a year ago.

Analysts expected the company to report net income of $0.19 per share for the period.

Revenues increased 0.6% to $107.3 million from $106.6 million a year ago.

FY Outlook

Revenues to be in the range of $424 million to $432 million.

EPS to be in the range of $0.65 to $0.73.

Analysts expect the company to report net income of $0.70 per share on revenues of $435.2 million for the period.

***

Adamas Pharmaceuticals, Inc. (ADMS)

Q4 net loss attributable to common stockholders was $10.7 million, or $0.58 per share vs. net income attributable to common stockholders of $9.7 million, or $0.50 per share a year ago.

Revenue was $0.5 million vs. $30.3 million a year ago.

***

Ultra Clean Holdings, Inc. (UCTT)

Q4 net loss for the fourth quarter was $15.8 million, or $0.49 per share compared to net income of $3.5 million, or $0.12 per share for the same period a year ago.

Non-GAAP net loss was $0.4 million, or $0.01 per share.

Total revenue for the fourth quarter was $103.42 million vs. $120.02 million a year ago.

Q1 Outlook

Revenue to be in the range of $108.0 million to $113.0 million and net income (loss) per share in the range of $(0.02) to $0.01.

Non-GAAP income per share to be in the range of $0.01 to $0.04.

***

Etsy, Inc. (ETSY)

Q4 net loss was $4.2 million or $0.04 per share compared with a $5.4 million or $0.12 per share net loss last year.

Total revenue was $87.9 million vs. $64.91 million a year ago.

***

eHealth, Inc. (EHTH)

Q4 net loss was $12.1 million, or $0.67 per share, compared to a net loss of $19.2 million, or $1.08 per share a year ago.

Non-GAAP net loss for the fourth quarter was $10.2 million, or $0.56 per share, compared to loss of $7.8 million, or $0.44 per share a year ago.

Revenue for fourth quarter was $50.1 million vs. $45.0 million a year ago.

FY Outlook

Total revenue is expected to be in the range of $195 million to $203 million.

Non-GAAP net income per share is expected to be in the range of $0.38 to $0.68.

***

Benefitfocus, Inc. (BNFT)

Q4 net loss was $12.49 million or $0.43 per share vs. net loss of $13.69 million or $0.54 per share a year ago.

Q4 non-GAAP net loss was $9.5 million or $0.33 per share compared to loss of $11.6 million or $0.45 per share a year ago.

Total revenue was $54.34 million vs. $40.19 million a year ago.

Q1 Outlook

Total revenue is expected to be in the range of $54.0 million to $54.5 million.

Non-GAAP net loss per share is expected to be in the range $0.42 to $0.40.

FY Outlook

Total revenue is expected to be in the range of $231.0 million to $235.0 million.

Non-GAAP net loss per share is expected to be in the range of $1.22 to $1.09.

***

Ternium S.A. (TX)

Q4 net loss was $126.5 million or $0.64 per ADS vs. net income of $71.4 million or $0.27 per ADS a year ago.

Net sales were $1.810 billion vs. $2.155 billion a year ago.

***

ExamWorks Group, Inc. (EXAM)

Q4 net income was $4.28 million or $0.10 per share vs. $3.84 million or $0.09 per share a year ago.

Analysts expected the company to report net income of $0.05 per share for the period.

Revenues for the fourth quarter were $208.5 million vs. $202.1 million a year ago.

Q1 Outlook

Revenues are expected to range between $216 million and $222 million.

Analysts expect the company to report revenues of $216.36 million for the period.

FY Outlook

Revenue is expected to increase between 14% and 16%.

Analysts expect the company to report revenue growth of 11.2% for the period.

***

Convergys Corporation (CVG)

Q4 GAAP net income from continuing operations was $43 million, or $0.41 per share, compared with $48 million, or $0.46 per share, in the same period last year.

Adjusted net income from continuing operations was $55 million, or $0.53 per share, compared with $54 million, or $0.52 per share, in the same period last year.

Analysts expected the company to report net income of $0.47 per share for the period.

Revenue was $752 million compared with $764 million in the same period last year.

***

CafePress Inc. (PRSS)

Q4 GAAP net income from continuing operations was $0.8 million, or $0.05 per share, compared to a net loss of $0.6 million, or $0.03 per share a year ago.

Non-GAAP net income from continuing operations was $1.8 million, or $0.11 per share, compared to loss of $0.7 million, or $0.04 per share a year ago.

Analysts expected the company to report net income of $0.05 per share for the period.

Net revenues totaled $39.7 million, compared to $50.4 million a year ago.

***

Avis Budget Group, Inc. (CAR)

Q4 GAAP net loss was $5 million, or $0.06 per share vs. net income of $23 million or $0.21 per share a year ago.

Adjusted net income was $18 million, or $0.18 per share vs. $25 million or $0.23 per share a year ago.

Analysts expected the company to report net income of $0.17 per share for the period.

Net revenues were $1.902 billion vs. $1.887 billion a year ago.

FY Outlook

Revenue to be in the range of $8.7 billion to $8.85 billion.

Analysts expect the company to report revenues of $8.77 billion for the period.

***

JBT Corporation (JBT)

Q4 net income was $20.9 million or $0.70 per share vs. $15.2 million or $0.51 per share a year ago.

Analysts expect the company to report net income of $0.62 per share for the period.

Revenue was $354.4 million vs. $295.4 million a year ago.

FY Outlook

Revenue growth of approximately 15 percent.

Adjusted earnings per share to be in the range of $2.15 - $2.30

GAAP EPS to be in the range of $1.90 - $2.05.

Analysts expect the company to report net income of $2.11 per share on revenue growth of 9.6% for the period.

***

Dycom Industries, Inc. (DY)

Q2 net income was $15.5 million, or $0.46 per share compared to $9.4 million, or $0.27 per share a year ago.

Adjusted net income was $18.0 million, or $0.54 per share.

Analysts expected the company to report net income of $0.57 per share for the period.

Contract revenues were $559.5 million compared to $441.1 million a year ago.

Q3 Outlook

Total contract revenues to range from $585 million to $605 million.

Non-GAAP EPS to range from $0.70 to $0.78.

Analysts expect the company to report net income of $0.85 per share on revenues of $593.19 million for the period.

***

Stanley Furniture Company, Inc. (STLY)

Q4 net income from continuing operations was $919,000, or $.06 per share, compared to net loss of $2.5 million or $0.18 per share a year ago.

Adjusted EPS was $0.03 vs. 0.00 a year ago.

Q4 net sales were $13.8 million compared to $16.0 million a year ago.

***

The Advisory Board Company (ABCO)

Q4 net loss attributable to common stockholders was $101.8 million, or $2.43 per share compared to net loss of $5.4 million, or $0.15 per share a year ago.

Non-GAAP earnings per share was $0.48 for the quarter, up from $0.24 a year ago.

Analysts expected the company to report net income of $0.30 per share for the period.

Revenue increased 38% to $205.0 million in the quarter from $149.0 million a year ago.

FY Outlook

Revenue to be in a range of $810 million to $830 million.

Non-GAAP earnings per share to be in a range of $1.63 to $1.73.

Analysts expect the company to report net income of $1.68 per share on revenues of $893.17 million for the period.

***

Comfort Systems USA, Inc. (FIX)

Q4 net income attributable to Comfort Systems USA was $13.22 million or $0.35 per share as compared to $10.68 million or $0.29 per share a year ago.

Analysts expected the company to report net income of $0.33 per share for the period.

Revenue was $383.84 million in the current quarter, as compared to $356.47 million a year ago.

***

U.S. Silica Holdings, Inc. (SLCA)

Q4 net loss was $15.3 million or $0.29 per share compared with net income of $33.2 million or $0.61 per share a year ago.

Revenue totaled $136.1 million compared with $249.6 million for the same period last year,

***

Golden Star Resources Ltd. (GSS)

Q4 net income attributable to Golden Star shareholders was $13.78 million or $0.05 per share vs. net loss of $48.16 million or $0.19 per share a year ago.

Adjusted net income attributable to Golden Star shareholders was $6.83 million or $0.03 per share

Analysts expect the company to report net loss of $0.02 per share for the period.

Revenue was $56.42 million vs. $86.59 million a year ago.

***

Analysen zu Jazz Pharmaceuticals PLCmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Jazz Pharmaceuticals PLC 86,86 -1,18% Jazz Pharmaceuticals PLC